Literature DB >> 8917084

Isolation of a Candida glabrata centromere and its use in construction of plasmid vectors.

K Kitada1, E Yamaguchi, M Arisawa.   

Abstract

A centromere has been isolated from Candida glabrata by functional selection based on the lethality of the SUP11 gene at high copy number. Nucleotide sequence analysis revealed a centromeric structure similar to that of Saccharomyces cerevisiae: the two highly conserved elements CDEI (8 bp) and CDEIII (26 bp) are separated by a 79-bp A+T-rich element, CDEII. Three centromere-bearing plasmid vectors with different selection markers have been constructed. These plasmids were highly stable in mitosis (< 1% loss rate per generation) and exist in one or two copies per cell.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917084     DOI: 10.1016/0378-1119(96)00132-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  33 in total

1.  Multifunctional centromere binding factor 1 is essential for chromosome segregation in the human pathogenic yeast Candida glabrata.

Authors:  T Stoyan; G Gloeckner; S Diekmann; J Carbon
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.

Authors:  Taiga Miyazaki; Shunsuke Yamauchi; Tatsuo Inamine; Yosuke Nagayoshi; Tomomi Saijo; Koichi Izumikawa; Masafumi Seki; Hiroshi Kakeya; Yoshihiro Yamamoto; Katsunori Yanagihara; Yoshitsugu Miyazaki; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2010-01-25       Impact factor: 5.191

3.  Phenotypic switching in Candida glabrata accompanied by changes in expression of genes with deduced functions in copper detoxification and stress.

Authors:  Thyagarajan Srikantha; Rui Zhao; Karla Daniels; Josh Radke; David R Soll
Journal:  Eukaryot Cell       Date:  2005-08

4.  The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.

Authors:  D Sanglard; F Ischer; D Calabrese; P A Majcherczyk; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  STB5 is a negative regulator of azole resistance in Candida glabrata.

Authors:  Jason A Noble; Huei-Fung Tsai; Sara D Suffis; Qin Su; Timothy G Myers; John E Bennett
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

6.  Inactivation of transcription factor gene ACE2 in the fungal pathogen Candida glabrata results in hypervirulence.

Authors:  Mohammed Kamran; Ana-Maria Calcagno; Helen Findon; Elaine Bignell; Michael D Jones; Peter Warn; Philip Hopkins; David W Denning; Geraldine Butler; Thomas Rogers; Fritz A Mühlschlegel; Ken Haynes
Journal:  Eukaryot Cell       Date:  2004-04

7.  Development of a Candida glabrata dominant nutritional transformation marker utilizing the Aspergillus nidulans acetamidase gene (amdS).

Authors:  Jianmin Fu; Morganne Blaylock; Cameron F Wickes; William Welte; Adrian Mehrtash; Nathan Wiederhold; Brian L Wickes
Journal:  FEMS Yeast Res       Date:  2016-03-13       Impact factor: 2.796

8.  Candida glabrata environmental stress response involves Saccharomyces cerevisiae Msn2/4 orthologous transcription factors.

Authors:  Andreas Roetzer; Christa Gregori; Ann Marie Jennings; Jessica Quintin; Dominique Ferrandon; Geraldine Butler; Karl Kuchler; Gustav Ammerer; Christoph Schüller
Journal:  Mol Microbiol       Date:  2008-06-28       Impact factor: 3.501

9.  Autophagy supports Candida glabrata survival during phagocytosis.

Authors:  Andreas Roetzer; Nina Gratz; Pavel Kovarik; Christoph Schüller
Journal:  Cell Microbiol       Date:  2009-10-06       Impact factor: 3.715

10.  Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence.

Authors:  Sélène Ferrari; Françoise Ischer; David Calabrese; Brunella Posteraro; Maurizio Sanguinetti; Giovanni Fadda; Bettina Rohde; Christopher Bauser; Oliver Bader; Dominique Sanglard
Journal:  PLoS Pathog       Date:  2009-01-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.